期刊文献+

沙培林在乳腺癌术中的局部应用 被引量:2

Local application of Sapylin(OK-432) during operation of breast cancer
原文传递
导出
摘要 目的探讨沙培林在乳腺癌术中局部应用的有效性。方法随机抽取120例乳腺癌患者,所有患者均行改良根治或根治术,其中实验组60例患者术中术野局部予以沙培林浸泡,对照组60例患者术野局部不予以沙培林浸泡。观察患者术后伤口引流量、住院天数、术后5年生存率及局部复发率。结果实验组患者术后伤口引流量及住院天数均少于对照组,差异有极显著性(P<0.01);两组患者术后5年生存率比较差异无显著性(P>0.05);实验组局部复发率明显低于对照组,差异有极显著性(P<0.01)。结论乳腺癌术中局部应用沙培林可减少引流量及住院天数,有效降低局部复发率,值得临床推广使用。 Objective To explore the efffectiveness of local application of Sapylin (0K-432) during operation of breast cancer. Methods 120 cases of breast cancer accepted the modified radical mastectomy or radical mastectomy were randomly divided into 2 groups: one group was given local application of Sapylin which was marinated in operation field, another was control group which was not given Sapylin . The drainage volume from operation wound, hospital days, surival rate for 5 years and local relapse rate after operation were observed. Results The drainage volume and hospital days in the experimental group were less than those in the control group, and the differences were significant( P 〈 0. 01 ) ; but the difference of the surival rate for 5 years after operation between the two groups was not significant ( P 〉 0.05 ). The local relapse rate in the experimental group was significantly lower than that in the control group, and the difference was significant(P 〈 0. 01 ). Conclusions Using Sapylin during operation of breast cancer is in favor of reducing the drainage volume and hospital days, and decreasing the local relapse rate. So this therapy is worthy of popularization for clinical use.
出处 《中国肿瘤临床与康复》 2009年第1期47-48,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 沙培林 乳腺肿瘤 药物疗法 Sapylin(OK-432) Breast neoplasms/drug therapy
  • 相关文献

参考文献3

二级参考文献11

  • 1赵家美 廖美琳 等.沙培林对癌性胸腔积液的疗效观察[J].中华结核和呼吸杂志,1994,(17):161-161.
  • 2Uchida A. Lysis of fresh human tumor by cytokines released from lymphocytes and its augmentation by the streptococcal preparation OK- 432. [M]// Micksche M,Klein E.OK- 432 A biological response modifier. Thomson Professional postgraduate services, 1986: 3
  • 3Torisu M, Katano M, Kimura Y, et al. New approach to management of malignant ascites with a streptococcal prepatation. OK-432:l.Improvement of host immunity and prolongation of survival[J]. Surgery, 1983,93(3):357-367.
  • 4Ishida N. Immunopoteniating activities of OK-432. Recent advances in the understanding of its mechanism of action[J].Excerpta Medical, 1986, (1): 41-84.
  • 5Imaoka S, Sasaki Y, Ishikawa O, et al.Immunochemotherapy in human hepatocellular carcinoma using the streptococcal agent OK-432[J]. J Clin Oncol, 1986, 4(11): 1645-1651.
  • 6Oshimi K, Kano S, Takaku F, et al. Augmentation of mouse natural killer cell activity by a streptococcal preparation,OK-432 [J]. J Natl Cancer Inst,1980, 65(6):1265-1269.
  • 7张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1998.1446.
  • 8宫笑鸰,李岩,主编.肿瘤基础与临床研究进展[M].香港:世界医学出版社,2000:193-194.
  • 9李树玲,刘奇,主编.乳腺癌研究进展[M].济南:济南出版社,1996:475-476.
  • 10林本耀,王天峰.乳腺癌保留乳房治疗之我见[J].中国肿瘤,1999,8(3):130-131. 被引量:61

共引文献5

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部